From 2013 to 2023, Italy has seen significant growth in high-tech pharmaceutical imports, with import values rising from 7.75 billion euros to 18.72 billion euros. The year-on-year variations show substantial fluctuations, with double-digit growth in some years, particularly in 2017 and 2018, and a slight decline in 2020. The Compound Annual Growth Rate (CAGR) averaged 6.36% over the past five years up to 2023.

Future projections indicate a steady upward trend. The forecast values for 2028 predict an import value of 23.64 billion euros, with an average annual growth rate of 3.69% from 2024 to 2028, amounting to a projected 19.84% growth over this five-year period.

Future trends to watch for:

Impact of technological advancements on pharmaceutical imports.
Effects of regulatory changes and trade policies within and outside the EU.
Potential disruptions or accelerations due to global health crises or major pharmaceutical innovations.